Jack M. Su

958 total citations
24 papers, 631 citations indexed

About

Jack M. Su is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Jack M. Su has authored 24 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 11 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in Jack M. Su's work include Glioma Diagnosis and Treatment (18 papers), Neuroblastoma Research and Treatments (6 papers) and Brain Metastases and Treatment (5 papers). Jack M. Su is often cited by papers focused on Glioma Diagnosis and Treatment (18 papers), Neuroblastoma Research and Treatments (6 papers) and Brain Metastases and Treatment (5 papers). Jack M. Su collaborates with scholars based in United States, United Kingdom and Italy. Jack M. Su's co-authors include Murali Chintagumpala, Susan M. Blaney, Xiao‐Nan Li, Ching C. Lau, Arnold C. Paulino, Patrick Thompson, Adekunle M. Adesina, M. Fatih Okcu, Bin S. Teh and E. Brian Butler and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Jack M. Su

22 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack M. Su United States 15 314 297 155 139 121 24 631
Stephen W. Gilheeney United States 15 346 1.1× 219 0.7× 93 0.6× 196 1.4× 179 1.5× 36 608
Kevin C. De Braganca United States 13 267 0.9× 272 0.9× 196 1.3× 108 0.8× 152 1.3× 34 613
Alfred Yung United States 16 370 1.2× 279 0.9× 167 1.1× 79 0.6× 179 1.5× 29 672
Paul L. Moots United States 13 424 1.4× 144 0.5× 80 0.5× 141 1.0× 133 1.1× 26 792
Nasjla Saba da Silva Brazil 10 391 1.2× 163 0.5× 60 0.4× 209 1.5× 97 0.8× 25 535
J. Robert Flamini United States 8 120 0.4× 277 0.9× 275 1.8× 132 0.9× 193 1.6× 14 1.0k
Wafik Zaky United States 12 271 0.9× 200 0.7× 59 0.4× 110 0.8× 92 0.8× 66 461
Hinke F. van Thuijl Netherlands 7 356 1.1× 200 0.7× 95 0.6× 66 0.5× 193 1.6× 11 693
Almuth F. Keßler Germany 16 275 0.9× 203 0.7× 209 1.3× 99 0.7× 101 0.8× 57 704
Mohamed S Abdelbaki United States 12 191 0.6× 137 0.5× 128 0.8× 113 0.8× 83 0.7× 64 528

Countries citing papers authored by Jack M. Su

Since Specialization
Citations

This map shows the geographic impact of Jack M. Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack M. Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack M. Su more than expected).

Fields of papers citing papers by Jack M. Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack M. Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack M. Su. The network helps show where Jack M. Su may publish in the future.

Co-authorship network of co-authors of Jack M. Su

This figure shows the co-authorship network connecting the top 25 collaborators of Jack M. Su. A scholar is included among the top collaborators of Jack M. Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack M. Su. Jack M. Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hanania, Alexander N., Arnold C. Paulino, Ethan B. Ludmir, et al.. (2021). Early radiotherapy preserves vision in sporadic optic pathway glioma. Cancer. 127(13). 2358–2367. 12 indexed citations
3.
Baxter, Patricia, Jack M. Su, Arzu Onar‐Thomas, et al.. (2020). A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study. Neuro-Oncology. 22(6). 875–885. 66 indexed citations
6.
Teo, Wan‐Yee, M. Tarek Elghetany, Jianhe Shen, et al.. (2014). Therapeutic implications of CD1d expression and tumor-infiltrating macrophages in pediatric medulloblastomas. Journal of Neuro-Oncology. 120(2). 293–301. 14 indexed citations
7.
Kilburn, Lindsay, Mehmet Koçak, Cynthia Wetmore, et al.. (2014). A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study. Neuro-Oncology. 17(2). 303–311. 9 indexed citations
8.
Su, Jack M., Patrick Thompson, Xiao‐Nan Li, et al.. (2014). A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a Pediatric Brain Tumor Consortium report†. Neuro-Oncology. 16(12). 1661–1668. 55 indexed citations
9.
Su, Jack M., Patrick A. Thompson, Xiao‐Nan Li, et al.. (2013). A phase I clinical trial of veliparib and temozolomide in children with recurrent central nervous system tumors: A Pediatric Brain Tumor Consortium report.. Journal of Clinical Oncology. 31(15_suppl). 2036–2036. 3 indexed citations
10.
Terashima, Keita, Alexander Yu, Peikai Chen, et al.. (2013). Genome‐wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors. Pediatric Blood & Cancer. 61(4). 593–600. 29 indexed citations
11.
Teo, Wan‐Yee, Jianhe Shen, Jack M. Su, et al.. (2013). Implications of Tumor Location on Subtypes of Medulloblastoma. Pediatric Blood & Cancer. 60(9). 1408–1410. 40 indexed citations
12.
Hwang, Steven W., Jack M. Su, & Andrew Jea. (2012). Diagnosis and management of brain and spinal cord tumors in the neonate. Seminars in Fetal and Neonatal Medicine. 17(4). 202–206. 20 indexed citations
13.
Blaney, Susan M., Michael Tagen, Arzu Onar‐Thomas, et al.. (2012). A phase‐1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: A pediatric brain tumor consortium study. Pediatric Blood & Cancer. 60(4). 627–632. 15 indexed citations
14.
Paulino, Arnold C., Bin S. Teh, M. Fatih Okcu, et al.. (2010). Ototoxicity After Intensity-Modulated Radiation Therapy and Cisplatin-Based Chemotherapy in Children With Medulloblastoma. International Journal of Radiation Oncology*Biology*Physics. 78(5). 1445–1450. 78 indexed citations
15.
Paulino, Arnold C., Ali Mazloom, Bin S. Teh, et al.. (2010). Local control after craniospinal irradiation, intensity‐modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma. Cancer. 117(3). 635–641. 21 indexed citations
16.
Su, Jack M., Xiao‐Nan Li, Patrick Thompson, et al.. (2010). Phase 1 Study of Valproic Acid in Pediatric Patients with Refractory Solid or CNS Tumors: A Children's Oncology Group Report. Clinical Cancer Research. 17(3). 589–597. 88 indexed citations
17.
Muscal, Jodi A., Patrick A. Thompson, Vincent L. Giranda, et al.. (2009). Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates. Cancer Chemotherapy and Pharmacology. 65(3). 419–425. 28 indexed citations
18.
Kornguth, David, Jack M. Su, K.K. Ang, et al.. (2008). Valproic Acid Shows Normal Tissue Protection in a Rat Spinal Cord Model. International Journal of Radiation Oncology*Biology*Physics. 72(1). S697–S698. 2 indexed citations
19.
Wong, Kwong‐Kwok, Yvonne T.M. Tsang, Jack M. Su, et al.. (2006). Genome-Wide Allelic Imbalance Analysis of Pediatric Gliomas by Single Nucleotide Polymorphic Allele Array. Cancer Research. 66(23). 11172–11178. 56 indexed citations
20.
Su, Jack M., László Perlaky, Xiaonan Li, et al.. (2004). Comparison of Ethanol Versus Formalin Fixation on Preservation of Histology and RNA in Laser Capture Microdissected Brain Tissues. Brain Pathology. 14(2). 175–182. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026